Book Description
This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on April 1, 2004. The length of the article is 1104 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation Details
Title: FDA experts vote in favor of OTC sale of Plan B.(Across Specialties)(Food and Drug Administration)(over the counter)
Author: Elizabeth Mechcatie
Publication: Clinical Psychiatry News (Magazine/Journal)
Date: April 1, 2004
Publisher: International Medical News Group
Volume: 32 Issue: 4 Page: 101(1)Distributed by Thompson Gale
Excerpt. © Reprinted by permission. All rights reserved.
GAITHERSBURG, MD. -- If the levonorgestrel-only emergency contraceptive becomes available over the counter, as recommended by a Food and Drug Administration advisory panel, this option could halve the number of unintended pregnancies and abortions that occur in this country each year, according to some estimates.
At a joint meeting of the FDA's nonprescription drugs and reproductive health drugs advisory committees, the panels voted 23-4 in favor of the OTC switch for the product, which is marketed as Plan B.
Home
